Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inge Marie Svane

Showing results (11-20 of 312) with videos related to

Pageof 32
Sort By:
Oncoimmunology|May 8, 2015
Indoleamine 2,3-dioxygenase vaccinationMads Hald Andersen, Inge Marie Svane
Seminars in Immunopathology|October 13, 2016
Cancer immunotherapy in patients with preexisting autoimmune disordersMarco Donia, Magnus Pedersen, Inge Marie Svane
Molecular Biotechnology|June 11, 2008
Studies on mRNA electroporation of immature and mature dendritic cells: effects on their immunogenic potentialOzcan Met, Jens Eriksen, Inge Marie Svane
European Journal of Cancer (Oxford, England : 1990)|January 26, 2025
Neoadjuvant or perioperative immunotherapy for resectable melanoma: The need for biomarkersEva Ellebaek, Marco Donia, Inge Marie Svane
Cytotherapy|May 7, 2013
Silencing of the glucocorticoid-induced leucine zipper improves the immunogenicity of clinical-grade dendritic cellsDominique Cathelin, Özcan Met, Inge Marie Svane
European Urology|May 6, 2006
Therapeutic dendritic cell vaccination of patients with renal cell carcinomaAnnika Berntsen, Poul F Geertsen, Inge Marie Svane
Oncoimmunology|May 4, 2016
The controversial role of TNF in melanomaMarco Donia, Julie Westerlin Kjeldsen, Inge Marie Svane
Cells|July 8, 2020
T-Cell Gene Therapy in Cancer Immunotherapy: Why It Is No Longer Just CARs on The RoadMichael D Crowther, Inge Marie Svane, Özcan Met
Methods in Molecular Biology (Clifton, N.J.)|May 30, 2016
Immune Monitoring Using mRNA-Transfected Dendritic CellsTroels Holz Borch, Inge Marie Svane, Özcan Met
Oncotarget|July 31, 2019
Real-world evidence to guide healthcare policies in oncologyMarco Donia, Steen Werner Hansen, Inge Marie Svane
Pageof 32

Showing results (11-20 of 312) with videos related to

Sort By:
Pageof 32
Oncoimmunology|May 8, 2015
Indoleamine 2,3-dioxygenase vaccinationMads Hald Andersen, Inge Marie Svane
Seminars in Immunopathology|October 13, 2016
Cancer immunotherapy in patients with preexisting autoimmune disordersMarco Donia, Magnus Pedersen, Inge Marie Svane
Molecular Biotechnology|June 11, 2008
Studies on mRNA electroporation of immature and mature dendritic cells: effects on their immunogenic potentialOzcan Met, Jens Eriksen, Inge Marie Svane
European Journal of Cancer (Oxford, England : 1990)|January 26, 2025
Neoadjuvant or perioperative immunotherapy for resectable melanoma: The need for biomarkersEva Ellebaek, Marco Donia, Inge Marie Svane
Cytotherapy|May 7, 2013
Silencing of the glucocorticoid-induced leucine zipper improves the immunogenicity of clinical-grade dendritic cellsDominique Cathelin, Özcan Met, Inge Marie Svane
European Urology|May 6, 2006
Therapeutic dendritic cell vaccination of patients with renal cell carcinomaAnnika Berntsen, Poul F Geertsen, Inge Marie Svane
Oncoimmunology|May 4, 2016
The controversial role of TNF in melanomaMarco Donia, Julie Westerlin Kjeldsen, Inge Marie Svane
Cells|July 8, 2020
T-Cell Gene Therapy in Cancer Immunotherapy: Why It Is No Longer Just CARs on The RoadMichael D Crowther, Inge Marie Svane, Özcan Met
Methods in Molecular Biology (Clifton, N.J.)|May 30, 2016
Immune Monitoring Using mRNA-Transfected Dendritic CellsTroels Holz Borch, Inge Marie Svane, Özcan Met
Oncotarget|July 31, 2019
Real-world evidence to guide healthcare policies in oncologyMarco Donia, Steen Werner Hansen, Inge Marie Svane
Pageof 32